Clinical Study
Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia
Figure 2
Effect of LA treatment on PTX3 peptide expression (ELISA) (a) and change in expression in all patients (b) and by LA schedule (c) in patients with HyperLp(a) (). LA, lipoprotein apheresis; PTX3, pentraxin; ELISA, enzyme-linked immunosorbent assay; HyperLp(a), hyperLp(a)lipoproteinemia; POST1, blood sample collected after first LA session; PRE2, blood sample collected before second LA session; POST2, blood sample collected after second LA session.
(a) |
(b) |
(c) |